跳至主要内容
临床试验/ISRCTN32675862
ISRCTN32675862已完成不适用

Treatment strategies for Rheumatoid Arthritis (BeSt - BehandelStrategieën in Reumatoïde Artritis)

eiden University Medical Centre (LUMC) (Netherlands)0 个研究点目标入组 508 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
508

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients (18 years or older) with rheumatoid arthritis (American College of Rheumatology [ACR] 1987 criteria)
  • 2. Diagnosis since less than two years
  • 3. Previously untreated with DMARDs
  • 4. With active disease (at least 6/66 swollen and at least 6/68 painful joints, and either Erythrocyte Sedimentation Rate [ESR] 28 mm or more or Visual Analogue Scale [VAS] general well being (by patient) of 20 mm or more)

排除标准

  • 1. Previous therapy with DMARDs except for hydroxychloroquine
  • 2. Pregnancy or wish to become pregnant during the study, or childbearing potential without adequate contraception
  • 3. Concomitant treatment with another experimental drug
  • 4. History or presence of malignancy within the last five years
  • 5. Bone marrow hypoplasia
  • 6. Elevated hepatic enzyme levels (Aspartate Aminotransferase [ASAT], Alanine Aminotransferase [ALAT] greater than three times normal value)
  • 7. Serum creatinine level greater than 150 umol/l or estimated creatinine clearance of less than 75 ml/min
  • 8. Diabetes mellitus
  • 9. Alcohol or drug abuse

研究者

发起方
eiden University Medical Centre (LUMC) (Netherlands)

相似试验